loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2007_157___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Bachem AG

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 BACHEM AMERICAS, INC. Torrance US (1)

    filter

    01 Desmopressin (1)

    filter

    01 Switzerland (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    BACHEM AMERICAS, INC. Torrance US

    Contact Supplier
    • FDA
    • EDQM
    • Audit Compliance
    Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
    Contact Supplier Contact Supplier
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Desmopressin

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2007-157 - Rev 02
    Valid
    Chemical
    2023-06-29
    712
    Bachem company banner

    CPhI North America

    Attending

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2007-157 - Rev 02 of Bachem Americas, Inc. Torrance Us

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2007-157 - Rev 02 of Bachem Americas, Inc. Torrance Us 1

    20

    Bachem Americas, Inc. Torrance Us, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    One of their significant offerings is Desmopressin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2007-157 - Rev 02

    This Chemical Type CEP, issued on June 29, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 712 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY